Rezolute (RZLT) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Rezolute insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $217K and 0 sold $0 of RZLT stock on the open market, including a cluster buy that began Dec 15, 2025.
Get emailed when insiders cluster-buy stocks like RZLT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RZLT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $28K | 1 | — | 0 |
| Q4 2025 | $207K | 8 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 Rezolute, Inc. insiders reported open-market purchases totaling $217K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Dec 15, 2025, when 4 insiders bought a combined $189K. Among insiders with enough purchase history to measure, Daron Evans (CFO) has the highest Insider Score at 97.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 31SEC | Daron EvansCFO | Buy | 10,000414,462 held (+2%) | $2.85 | $28K | +70.9% | 97 |
| Dec 17SEC | Brian Kenneth RobertsChief Medical Officer | Buy | 28,000308,352 held (+10%) | $1.70 | $48K | +186.5% | — |
| Dec 17SEC | Wladimir HogenhuisDirector | Buy | 5,650119,675 held (+5%) | $1.69 | $10K | +188.2% | — |
| Dec 15SEC | Daron EvansCFO | Buy | 40,000415,900 held (+11%) | $1.77 | $71K | +175.1% | 97 |
| Dec 15SEC | Nevan C ElamCEO | Buy | 32,000641,119 held (+5%) | $1.59 | $51K | +206.3% | — |
| Dec 15SEC | Sunil Ratilal KarnawatChief Commercial Officer | Buy | 12,00071,442 held (+20%) | $1.62 | $19K | +200.6% | — |
| Dec 15SEC | Daron EvansCFO | Buy | 2,5007,000 held (+56%) | $1.79 | $4K | +172.1% | 97 |
| Dec 15SEC | Daron EvansCFO | Buy | 2,5007,000 held (+56%) | $1.79 | $4K | +172.1% | 97 |
| Dec 15SEC | Sunil Ratilal KarnawatChief Commercial Officer | Buy | 10071,542 held (+0%) | $1.60 | $160 | +204.4% | — |
Insiders at Rezolute, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Daron EvansCFO | $108K | — | Mar 31, 2026 | 97 |
| Nevan C ElamCEO | $51K | — | Dec 15, 2025 | — |
| Brian Kenneth RobertsChief Medical Officer | $48K | — | Dec 17, 2025 | — |
| Sunil Ratilal KarnawatChief Commercial Officer | $20K | — | Dec 15, 2025 | — |
| Wladimir HogenhuisDirector | $10K | — | Dec 17, 2025 | — |
RZLT stock: common questions
Are Rezolute, Inc. insiders buying RZLT stock?
In the past 12 months, 4 insiders reported open-market purchases of RZLT worth $217K. The latest was CFO Daron Evans bought $28K of RZLT at $2.85.
Are Rezolute, Inc. insiders selling RZLT stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RZLT's 52-week range?
Over the past year RZLT has traded between $1.40 and $10.94. It last closed at $4.87 on Oct 9, 2026.